IARAX
Price
$17.12
Change
-$0.05 (-0.29%)
Updated
Jul 25 closing price
Net Assets
743.35M
VGSIX
Price
$30.49
Change
+$0.01 (+0.03%)
Updated
Jul 25 closing price
Net Assets
63.79B
Interact to see
Advertisement

IARAX vs VGSIX

Header iconIARAX vs VGSIX Comparison
Open Charts IARAX vs VGSIXBanner chart's image
Invesco Real Estate A
Price$17.12
Change-$0.05 (-0.29%)
VolumeN/A
Net Assets743.35M
Vanguard Real Estate Index Investor
Price$30.49
Change+$0.01 (+0.03%)
VolumeN/A
Net Assets63.79B
IARAX vs VGSIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IARAX vs. VGSIX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IARAX is a Buy and VGSIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSIX has more cash in the bank: 63.8B vs. IARAX (743M). VGSIX pays higher dividends than IARAX: VGSIX (3.75) vs IARAX (2.12). IARAX was incepted earlier than VGSIX: IARAX (29 years) vs VGSIX (29 years). IARAX (1.38) is less costly to investors than VGSIX (0.27). IARAX is a more actively managed with annual turnover of: 63.00 vs. VGSIX (7.00). VGSIX has a lower initial minimum investment than IARAX: VGSIX (0) vs IARAX (1000). VGSIX annual gain was more profitable for investors over the last year : 8.10 vs. IARAX (2.26). VGSIX return over 5 years is better than : 41.03 vs. IARAX (6.47).
IARAXVGSIXIARAX / VGSIX
Total Expense Ratio1.380.27511%
Annual Report Gross Expense Ratio1.380.27511%
Fund Existence29 years29 years-
Gain YTD2.7154.92055%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets743M63.8B1%
Annual Yield % from dividends2.123.7557%
Returns for 1 year2.268.1028%
Returns for 3 years-10.699.41-114%
Returns for 5 years6.4741.0316%
Returns for 10 years-22.7463.27-36%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTGC19.440.01
+0.05%
Hercules Capital
SPRO2.33-0.02
-0.85%
Spero Therapeutics
EXPE187.34-3.14
-1.65%
Expedia Group
EVGN1.31-0.04
-2.96%
Evogene Ltd.
AUTL2.52-0.12
-4.55%
Autolus Therapeutics plc